Greenwich LifeSciences, Inc. (GLSI) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 876 | 903 | 903 | 903 | 903 | 903 | 903 | 903 | 903 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | -876 | -903 | -903 | -903 | -903 | -903 | -903 | -903 | -903 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | 100% | 100% | 100% | 2.99% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Operating Expenses | 5.73M | 7.94M | 4.17M | 4.05M | 2.77M | 8.08M | 2.73M | 2.66M | 2.54M | 2.84M | 2.5M | 1.75M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 518.19K | 653.07K | 653.07K | 538.05K | 496.7K | 1.93M | 437.01K | 353.53K | 341.79K | 502.15K | 344.76K | 368.26K |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 5.21M | 3.52M | 3.52M | 3.51M | 2.27M | 6.16M | 2.29M | 2.31M | 2.19M | 2.33M | 2.16M | 1.38M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.73M | -7.94M | -4.17M | -4.05M | -2.77M | -8.08M | -2.73M | -2.66M | -2.54M | -2.84M | -2.5M | -1.75M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -106.8% | 1.72% | -52.97% | -52.02% | -9.13% | -185.05% | -9.03% | -52.27% | -13.21% | 2.03% | -5.03% | -126.02% |
| EBITDA | -5.66M | -7.92M | -4.15M | -4.05M | -2.77M | -8.08M | -2.73M | -2.66M | -2.54M | -2.84M | -2.5M | -1.75M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -104.39% | 1.99% | -52.19% | -52.04% | -9.13% | -185.11% | -9.04% | -52.3% | -13.22% | 2.03% | -5.03% | -126.17% |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 | 876 | 903 | 903 | 903 | 903 | 903 | 903 | 903 | 903 |
| EBIT | -5.66M | -7.92M | -4.15M | -4.03M | -2.74M | -8.04M | -2.67M | -2.61M | -2.47M | -2.75M | -2.39M | -1.63M |
| Net Interest Income | 68.62K | 22.26K | 22.8K | 20.68K | 23.97K | 43.94K | 60.34K | 54.72K | 64.01K | 89.29K | 111.14K | 119.45K |
| Interest Income | 68.62K | 22.26K | 22.8K | 20.68K | 23.97K | 43.94K | 60.34K | 54.72K | 64.01K | 89.29K | 111.14K | 119.45K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 68.62K | 22.26K | 22.8K | 20.68K | 23.97K | 43.94K | 60.34K | 54.72K | 64.01K | 89.29K | 111.14K | 119.45K |
| Pretax Income | -5.66M | -7.92M | -4.15M | -4.03M | -2.74M | -8.04M | -2.67M | -2.61M | -2.47M | -2.75M | -2.39M | -1.63M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -5.66M | -7.92M | -4.15M | -4.03M | -2.74M | -8.04M | -2.67M | -2.61M | -2.47M | -2.75M | -2.39M | -1.63M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -106.11% | 1.46% | -55.57% | -54.42% | -10.98% | -192.72% | -11.58% | -60.08% | -16.39% | 1.57% | -3.14% | -118.26% |
| Net Income (Continuing) | -5.66M | -7.92M | -4.15M | -4.03M | -2.74M | -8.04M | -2.67M | -2.61M | -2.47M | -2.75M | -2.39M | -1.63M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.39 | -0.58 | -0.30 | -0.30 | -0.25 | -0.61 | -0.20 | -0.20 | -0.19 | -0.21 | -0.19 | -0.13 |
| EPS Growth % | -56% | 4.92% | -50% | -50% | -31.58% | -190.48% | -5.26% | -53.85% | -18.75% | 0% | -5.56% | -133.81% |
| EPS (Basic) | -0.39 | -0.58 | -0.30 | -0.30 | -0.25 | -0.61 | -0.20 | -0.20 | -0.19 | -0.21 | -0.19 | -0.13 |
| Diluted Shares Outstanding | 14.57M | 13.64M | 13.64M | 13.37M | 13.17M | 13.15M | 13.14M | 12.91M | 12.86M | 12.85M | 12.85M | 12.85M |
| Basic Shares Outstanding | 14.57M | 13.64M | 13.64M | 13.37M | 13.17M | 13.15M | 13.14M | 12.91M | 12.86M | 12.85M | 12.85M | 12.85M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |